rhinitis%20-%20nonallergic
RHINITIS - NONALLERGIC
Nonallergic rhinitis is the inflammation of the nasal lining membranes without any immunoglobulin E mediation, as documented by allergen skin testing.
Major signs and symptoms include nasal itching, watery rhinorrhea, nasal obstruction/congestion, sneezing and postnasal drainage.
Symptoms can reverse spontaneously with or without treatment.

Principles of Therapy

  • If possible, treatment should be aimed at the underlying causative physiology of nonallergic rhinitis
  • No single medication or individual medication class can treat the entire spectrum of symptoms
  • Treatment response may be less satisfactory than in allergic rhinitis

Pharmacotherapy

Anticholinergics (Nasal)
  • Block the muscarinic receptors of the seromucinous glands
  • Ipratropium is ideal for patients who present w/ watery rhinorrhea
  • Have no activity against sneezing, itching or nasal congestion
Antihistamines (Nasal)
  • H1-receptor antagonists reduce nasal itching, sneezing & rhinorrhea, but are less effective for nasal obstruction
  • May have limited benefit in nonallergic rhinitis unless symptoms result from histamine release
  • Oral antihistamines may be used as adjunctive therapy in some patients; topical antihistamines have shown better efficacy for nonallergic rhinitis
  • Azelastine, Olopatadine, & a combination of Azelastine & Fluticasone can reduce symptoms for over a year
Corticosteroids (Nasal)
  • Reduce airway hyperresponsiveness, amount & activity of inflammatory mediators, & allow relaxation of smooth muscle
  • Decrease sneezing, pruritus, rhinorrhea & nasal obstruction
  • Recommended as 1st-line treatment for symptoms of nonallergic rhinitis
  • Onset of action is relatively slow (6-12 hours), w/ maximum efficacy developing after 2-3 weeks
  • Better response is achieved w/ continuous use rather than w/ as-required use
  • Patient should be maintained on the lowest dose which achieves symptom control
  • Aqueous preparations are preferred because they are less irritating to the nasal mucosa
  • Intranasal corticosteroids w/ low bioavailability is suggested since it has been shown to have no effect on growth
Decongestants
  • Provoke vasoconstriction by acting on adrenergic receptors, thus relieving swelling of the nasal mucosa
Nasal Decongestants
  • Very effective in relieving nasal obstruction
  • Because of the risk of rebound vasodilation (rhinitis medicamentosa) & atrophic rhinitis w/ prolonged use, use should be limited to <10 days
Oral Decongestants
  • Have weaker effect on nasal obstruction than topical preparations, but do not cause rebound vasodilatation
  • May be given to patients w/ nasal congestion unresponsive to intranasal corticosteroids, Azelastine, or a combination of both

Aspirin (Nasal)
  • For patients w/ inflammatory nonallergic rhinitis that have not responded to anti-inflammatory therapy & combination therapy, an Aspirin challenge can be done followed by desensitization if positive

Non-Pharmacological Therapy

Nasal Saline Irrigation
  • Nasal lavage or saline spray is useful for postnasal drainage symptoms
  • Cleanses nasal mucosa when used before intranasal corticosteroids or Azelastine
Other Investigational Agents
  • Some studies show benefit of Capsaicin, Ribomunyl & Silver nitrate for rhinitis symptoms
    • Capsaicin & Silver nitrate may be used for vasomotor rhinitis & Ribomunyl for infectious rhinitis
    • Topical Capsaicin desensitization reduces symptoms for several months
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
12 Apr 2019
Long-acting beta2-agonist (LABA) plus long-acting muscarinic antagonist (LAMA) combinations compare with inhalers containing both LABA and corticosteroid (LABA-ICS) in terms of reducing chronic obstructive pulmonary disease (COPD) exacerbations, although the LAMA-LABA combination is more favourable as it is associated with fewer episodes of severe pneumonia, according to a study.
16 Jan 2017
There are various ear, nose, and throat (ENT) conditions which present to the GP’s clinic. Dr Jason Hwang, an ENT Consultant from the Department of Otolaryngology at Gleneagles Hospital in Singapore, speaks on how the majority of the conditions can be effectively managed at the primary care level seeing that these can be treated medically without the need for surgical intervention.